People

Perlman-276x303
David C. Perlman, MD
CDUHR - Director, Infectious Disease Epidemiology and Theory Core
Mount Sinai Health System - Professor of Medicine, Icahn School of Medicine
Mount Sinai Health System - Chief, Infectious Diseases, Mount Sinai Beth Israel
Education
MD, Medicine, Albert Einstein College of Medicine
BA. Biochemistry & Anthropology, Dartmouth College
Research Interests
HIV, HCV, IDUs, Diagnosis and treatment
BIO
David Perlman has over 20 years’ experience in HIV, HCV, TB and STIs and remains active as a clinician in these areas. He has served as principal investigator on multi-center trials within NIAID’s AIDS Clinical Trials group, and on R01 grants from NIDA. He has served on NIH study sections, CDC consensus panels, and committees within the ACTG, the NYS DOH AIDS Institute, and the NYC DOMH. Dr. Perlman’s earlier work focused on studies of the epidemiology of tuberculosis among drug users, and on health care delivery models and behavioral and structural interventions to facilitate adherence to the TB and HIV/TB care continuum. Dr. Perlman’s recent work has focused on studies of barriers and facilitators of HIV and HCV testing and care among racial and ethnic minorities, high risk heterosexuals, and people who use drugs, and more broadly on studies of strategies to improve HIV and HIV/HCV care continua and prevention programming for these populations.
Projects
Principal Investigator, Hepatitis Care Coordination in Methadone Treatment. Completed
Publications

Recent

Guilamo-Ramos V, Benzekri A, Thimm-Kaiser M, Hidalgo A, Perlman DC (2020).
Reconsidering assumptions of adolescent and young adult SARS-CoV-2 transmission dynamics
Clinical Infectious Diseases [Epub 2020 Sep 7]. doi: 10.1093/cid/ciaa1348.

Jordan AE, Cleland CM, Wyka K, Schackman BR, Perlman DC, Nash D (2020).
Hepatitis C virus incidence in a cohort in medication-assisted treatment for opioid use disorder in New York City
Journal of Infectious Diseases, 222 (Supplement 5), S322-S334. doi: 10.1093/infdis/jiz659.

Jordan AE, Cleland CM, Schackman BR, Wyka K, Perlman DC, Nash D (2020).
Hepatitis C virus (HCV) care continuum outcomes and HCV community viral loads among patients in an opioid treatment program
Journal of Infectious Diseases, 222 (Supplement 5), S335-S345. doi: 10.1093/infdis/jiz686.

Jaiswal J, LoSchiavo C, Perlman DC (2020).
Disinformation, misinformation and inequality-driven mistrust in the time of COVID-19: Lessons unlearned from AIDS denialism
AIDS and Behavior [Epub 2020 May 21]. doi: 10.1007/s10461-020-02925-y. PMCID: PMC7241063.

Frimpong JA, Shiu-Yee K, Tross S, D'Aunno T, Perlman DC, Strauss SM, Schackman BR, Feaster DJ, Metsch LR (2020).
Bundling rapid human immunodeficiency virus and hepatitis C virus testing to increase receipt of test results: A randomized trial
Medical Care, 58 (5), 445-452. doi: 10.1097/MLR.0000000000001311.

Dr. Perlman's MyBibliography Profile